Milk thistle, containing silymarin, exhibits potential anti-cancer effects by targeting NF-κB, PI3K/Akt, and other pathways. Emerging research suggests metabolic modulation, apoptosis induction, and tumour growth inhibition. While preclinical data is promising, further clinical trials are required to confirm efficacy and safety in cancer management.
